Skip to content
SMA News Today logo
Newsletter
  • About SMA
    What is SMA?
    • Causes
    • Symptoms
    • Diagnosis
    • Prognosis
    Types
    • Type 0
    • Type 1
    • Type 2
    • Type 3
    • Type 4
    Treatments
    • Approved treatments
    • Experimental treatments
    • Non-drug treatments
  • Living with
    Living with SMA
    Mental health
    Managing fatigue
    Sleep tips
    Speech therapy
    Specialized equipment
    Flying with a wheelchair
  • Community
    Perspectives
    • Embracing My Inner Alien - Kevin Schaefer
    • Being Resilient - Jasmine Ramos
    • Soaring With Hope - Ari Anderson
    • Life, One Cup at a Time - Alyssa Silva
    • Wandering The Lines - Sherry Toh
    • The Wolf Finally Frees Itself - Brianna Albers
    • Caring Together - Connie Chandler
    • We’re Not in Kansas Anymore - Helen Baldwin
    • From Where I Sit - Halsey Blocher
    Guest Voices
    Videos
    • Building your healthcare team
    • Taking control of your healthcare
    • SMA love story
    • Smart home technology
    • Final SMA gift
    • Theme park preparation
    Features
    • Speaking out for the SMA community
    • Spinal cord stimulation
    Vlogs
    The SMA podcast
  • News
  • Forums
  • Resources
    SMA empowerment
    Find a physician
    Advocacy partners
    Quizzes
    • Genetics, diagnosis, and treatment

SMA News Today is providing live coverage of the MDA Clinical & Scientific Conference taking place March 16-19 in Dallas. Stay tuned to this page for all the latest news.

News

MDA 2025: Spinraza treatment stabilizes adult motor function

Treatment with Spinraza (nusinersen) can help stabilize motor function in adults with spinal muscular atrophy (SMA), according to a new analysis. “This study aligns with previously reported findings and suggests that long-term [treatment with Spinraza] offers sustained clinical benefits in adults with SMA,” researchers wrote in the abstract…

Doctor finder promo

Recent Posts

  • MDA 2026: Keynote speaker to MDA community: ‘Your voice is powerful’
  • Ahead of this year’s MDA Conference, association’s CEO speaks of ‘hope’
  • MDA 2025: Potassium channel could be SMA treatment target
  • MDA 2025: Apitegromab safely improves SMA motor function
  • MDA 2025: Evrysdi consistent after 5-year SUNFISH follow-up


  Subscribe to our newsletter

Get regular updates to your inbox.

This field is for validation purposes and should be left unchanged.

Bionews Logo Bionews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Website: bionews.com
Email: [email protected]
Phone: 1-800-936-1363

  • SMA News Today on Facebook
  • SMA News Today on X
  • SMA News Today on Instagram
  • SMA News Today on SoundCloud
  • SMA News Today on YouTube
  • SMA News Today on Pinterest
  • SMA News Today on Threads
  • About Us
    • Our Culture
    • Leadership
    • Careers
    • Contact Us
  • Explore More
    • Advertising Policy
    • Corrections Policy
    • Editorial Policy
    • Privacy Policy
    • Terms of Service
Disclaimer

This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2026 All rights reserved.

Log in

Don't have an account?

Log in

[wppb-login register_url="/register" lostpassword_url="/recover-password" ajax=true]

|

Register

Already have an account?

Register

Create your account by filling in the information below:

[wppb-register redirect_url="/welcome" ajax=true]

By creating an account, you are agreeing to the Privacy Policy and Terms of Service.

Reset Password

[wppb-recover-password ajax=true]